Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NSCLC (non-small Cell Lung Cancer)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00536861
What this trial is testing

Safety Study of Radiotherapy and Concurrent Erlotinib (Tarceva®) for Brain Metastases From a Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerBrain Metastases
Amsterdam UMC, location VUmc 11
Testing effectiveness (Phase 2)Study completedNCT00948961
What this trial is testing

CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1

Who this might be right for
Advanced Malignancies
Celldex Therapeutics 70
Large-scale testing (Phase 3)Active Not RecruitingNCT04687241
What this trial is testing

Almonertinib Versus Placebo as Adjuvant Therapy in Resected Stage II-IIIB Non-Small Cell Lung Cancer With EGFR-sensitive Mutations

Who this might be right for
Non-small Cell Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd. 192
Not applicableStudy completedNCT01067794
What this trial is testing

Chemotherapy in Treating Patients With Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 1,610
Testing effectiveness (Phase 2)UnknownNCT05468294
What this trial is testing

F16IL2 in Combination With Nivolumab in Patients With Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Philogen S.p.A. 3
Testing effectiveness (Phase 2)UnknownNCT02839954
What this trial is testing

CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor

Who this might be right for
Hepatocellular CarcinomaNon-small Cell Lung CancerPancreatic Carcinoma+4 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT04392505
What this trial is testing

Durvalumab(MEDI4736) After chemoRadioTherapy(DART) for NSCLC-a Translational and Biomarker Study

Who this might be right for
CancerNon Small Cell Lung CancerNon Small Cell Lung Cancer Stage III+2 more
Oslo University Hospital 100
Early research (Phase 1)Ended earlyNCT00288054
What this trial is testing

S0429: Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
SWOG Cancer Research Network 24
Not applicableEnded earlyNCT01137162
What this trial is testing

Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR Inhibitors

Who this might be right for
Anal, Colon, and Rectal CancersHead and Neck CancerLung Cancer+17 more
Stanford University 10
Not applicableUnknownNCT03956641
What this trial is testing

Evolution of the Physical Condition in Treated Cancer Patients

Who this might be right for
Non-small Cell Lung Cancer MetastaticBreast Cancer FemaleColon Cancer
Centre Paul Strauss 300
Early research (Phase 1)Ended earlyNCT03455556
What this trial is testing

Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer

Who this might be right for
Mesothelin PositiveStage III Non-Small Cell Lung Cancer AJCC v7Stage IIIA Non-Small Cell Lung Cancer AJCC v7+2 more
Mayo Clinic 1
Not applicableNot Yet RecruitingNCT07268469
What this trial is testing

Minimal Residual Disease in Solid Malignancies

Who this might be right for
Breast CancerNon Small Cell Lung CancerProstate Cancer+2 more
European Institute of Oncology 840
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Early research (Phase 1)Study completedNCT01664754
What this trial is testing

Exemestane, Pemetrexed Disodium, and Carboplatin in Treating Post-Menopausal Women With Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Stage IV Non-small Cell Lung Cancer
Jonsson Comprehensive Cancer Center 8
Large-scale testing (Phase 3)UnknownNCT04033354
What this trial is testing

A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC

Who this might be right for
Squamous Non Small Cell Lung Cancer
Shanghai Henlius Biotech 537
Testing effectiveness (Phase 2)Study completedNCT00387322
What this trial is testing

Pemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors

Who this might be right for
Lung CancerUnspecified Adult Solid Tumor, Protocol Specific
University of California, Davis 42
Testing effectiveness (Phase 2)UnknownNCT01624051
What this trial is testing

A Study Comparing Chemotherapy Dosing Based on Either Standard Body Surface Area or Lean Body Mass in Patients With Advanced Lung Cancer

Who this might be right for
Lung Cancer
AHS Cancer Control Alberta 144
Testing effectiveness (Phase 2)Study completedNCT03735680
What this trial is testing

Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer

Who this might be right for
Breast CancerHead and Neck Squamous Cell CarcinomaColorectal Cancer+4 more
OncoNano Medicine, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT00994123
What this trial is testing

MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Merrimack Pharmaceuticals 162
Testing effectiveness (Phase 2)UnknownNCT06018688
What this trial is testing

Osimertinib Combined With Aspirin Neoadjuvant Therapy for Resectable EGFR Mutated NSCLC Patients.

Who this might be right for
Non Small Cell Lung CancerEGFR Gene Mutation
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 44
Next Page